ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Thursday, November 14, 2019
15th ALS TDI Leadership Summit
On Friday, November 8, 2019, the ALS Therapy Development Institute (ALS TDI) hosted the 15th Leadership Summit.
read more
Thursday, October 24, 2019
The Clinical Trial Process | The Four Phases Explained
Developing a new drug and bringing it all the way through the clinical trial process is a long and difficult task.
read more
Tuesday, October 01, 2019
FDA Issues Guidance Document for ALS Clinical Trials
On September 23, 2019, the Food and Drug Administration (FDA) issued its most recent guidance document.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Tuesday, November 12, 2019
ALS TDI Joins International Symposium in Perth
In December 2019, the Motor Neuron Disease Association (MNDA) will be holding its annual International Symposium on ALS/MND from December 4th to 6th in Perth, Australia. Fernando Vieira, the Chief Scientific Officer of the ALS Therapy Development Institute (ALS TDI) will be in attendance.
read more
Monday, November 11, 2019
Brian Wallach Reflects on 2019 ALS TDI Leadership Summit
On Friday, 11/8/2019, Brian Wallach received the Stephen Heywood Patients Today Award. The award was
read more
Tuesday, November 05, 2019
The PeriodicALS: Volume 20 Issue 11
November news from the ALS Therapy Development Institute.
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Tuesday, November 19, 2019
AT-1501, A Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trial
Anelixis Therapeutics, a for-profit clinical-stage development company that brought the drug through trial, announced on Monday, November 18, that they completed a Phase 1 safety and pharmacokinetic study of AT-1501 in healthy subjects and people living with ALS.
read more
Wednesday, October 16, 2019
Brian Wallach, Glynis Murray, Lisa Cross Bonahoom, Jamey Spakes and Hugh Macdonnell receive 2019 ALS TDI Leadership Awards.
The ALS Therapy Development Institute (ALS TDI) is proud to announce the 2019 Leadership Award recipients. The ALS TDI Leadership Awards are presented each year to honor those who lead us in the battle against ALS. This year's recipients include Brian Wallach, Glynis Murray, Lisa Cross Bonahoom, Jamey Spakes and Hugh Macdonnell. The recipients were chosen from nominations made by members of the ALS community.
read more
Tuesday, October 01, 2019
FDA Issues Guidance Document for ALS Clinical Trials
On September 23, 2019, the Food and Drug Administration (FDA) issued its most recent guidance document.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.
×
December 3 is
Giving Tuesday
Celebrate #GivingTuesday by helping to
fund vital ALS research at ALS TDI.